首页> 外国专利> Compounds 2, trans - (4-aminocyclohexyl) amino - disustituidas purines 6.9,Pharmaceutical compositions and use of such compounds for the preparation of a Medicament for treating a disorder hiperproliferativo,To prevent apoptosis in neuronal cells and protect the cells neuronale

Compounds 2, trans - (4-aminocyclohexyl) amino - disustituidas purines 6.9,Pharmaceutical compositions and use of such compounds for the preparation of a Medicament for treating a disorder hiperproliferativo,To prevent apoptosis in neuronal cells and protect the cells neuronale

机译:化合物2,反式-[(4-氨基环己基)氨基]-二嘌呤嘌呤6.9,药物组合物和此类化合物在制备用于治疗hiperproliferativo疾病的药物中的用途,以防止神经元细胞凋亡并保护神经元细胞

摘要

Compounds of formula (i) wherein R is selected from the group consisting of R2, r2nh -Or r3r4n R5 - Where R2 is selected from the group formed poralquilo c9-12 of formula (ii) wherein R6 is selected independently from each group comprising Hydrogen, cycloalkyl C3 - 8C1-4 alkyl, and mfenilo (CH2), where a whole month 0 - 8; X is an integer - 1; n is integer 0 - 8; is selected from the group consisting of phenyl Heterocyclic cycloalkyl,,,Ynaftaleno; M is selected from the grupofo confirmed by Hydrogen, c1-4 alkyl, where each R6 is selected regardless of porhidrogeno cycloalkyl Group, C3 - 8C1-4 alkyl and phenyl - (CH2) m, where M is an integer of 0 - 8; n is an integer of 0 - 8; X is an integer Q 1 - 8; eshidrogeno or c1-4 alkyl; and Z is selected from the group consisting of phenyl Heterocycles.Cycloalkyl and alkyl naphthalene; and when each c9-12 or z is optionally substituted with 1 to 3 substituents, which can be same or different,And two are selected from the group formed by D, e, fig.III D seleccionadoindependientemente where each group is formed by trifluormetilo, trifluormetoxi c1-4 alkoxy, and E is selected independently; each group formed by Oh, Hal,Yalquilo C1 - 8; an integer B and S = - 2; Z is selected from the group consisting of phenyl Heterocycles.Cycloalkyl and R6 is seleccionadoindependientemente naphthalene; each group formed by Hydrogen, alkyl, cycloalkyl C1 - C3 - 8, 4 and M - (CH2) phenylWhere M is a Body ro 0 - 8; n is an integer of 0 - 8; X is an integer 1 to 8, and M is selected from the group consisting of hydrogen, c1-4 alkyl, formula IV,R6 is selected regardless where each group formed by Hydrogen, alkyl, cycloalkyl C1 - C3 - 8, 4 and (CH2) M phenylWhere M is a - 8 January 0; X is an integer 1 - 8; and q is Hydrogen or alquiloc1 - 4; and Z is selected from the group consisting of Heterocyclic cycloalkyl, phenyl and naphthaleneWhere the groups M and z can estarsustituidosopcionalmente with groups or Formula D and V where each R6 is selected regardless of the group consisting of hydrogen, cycloalkyl C3 - 8
机译:式(i)的化合物,其中R 2选自由R 2,r 2nh-或r 3r4n R 5-其中R 2选自式(ii)的形成的聚对苯并基c9-12,其中R 6独立地选自每个包含氢的基团,环烷基C3-8C1-4烷基和mfenilo(CH2),其中整个月为0-8; X是一个整数-1; n是0到8的整数;选自苯基杂环环烷基,Ynaftaleno; M选自氢,c 1-4烷基,其中每个R 6均与疏氢基环烷基,C 3-8 C1-4烷基和苯基-(CH 2)m无关,其中M为0-8的整数; n是0-8的整数; X是整数Q 1-8; eshidrogeno或c1-4烷基;环烷基和烷基萘;和Z选自苯基杂环。当每个c9-12或z任选地被1-3个相同或不同的取代基取代时,并且从D所形成的基团中选择两个,图III D硒代独立性,其中每个基团是由三氟美托基形成的,三氟甲氧基C 1-4烷氧基,和E独立地选择;每个小组由Oh,Hal,Yalquilo C1-8组成;整数B且S =-2; Z选自苯基杂环。环烷基和R 6是硒代独立萘。由氢,烷基,环烷基C 1 -C 3-8,4和M-(CH 2)苯基形成的每个基团,其中M是R 0-8的基团; n是0-8的整数; X为1至8的整数,并且M选自氢,c 1-4烷基,式IV,R 6,而与氢,烷基,环烷基C 1 -C 3-8,4和( CH2)M苯基其中M是-0年1月8日; X是1-8的整数;并且q是氢或alquiloc1-4; Z选自杂环环烷基,苯基和萘,其中基团M和z可以与具有式D和V的基团形成氨基,其中每个R6的选择均与氢,环烷基C3-8无关

著录项

  • 公开/公告号AR018121A1

    专利类型

  • 公开/公告日2001-10-31

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMACEUTICALS INC.;

    申请/专利号AR1999P100781

  • 发明设计人

    申请日1999-02-25

  • 分类号C07D473/16;A61K31/52;A61P35/00;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号